Filing Details
- Accession Number:
- 0000927066-17-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-11 18:44:49
- Reporting Period:
- 2017-12-07
- Accepted Time:
- 2017-12-11 18:44:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1415548 | Javier Rodriguez | C/O Davita Inc. 2000 16Th Street Denver CO 80202 | Chief Executive Officer, Dkc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-07 | 112,500 | $55.34 | 210,317 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-12-07 | 89,968 | $69.20 | 120,349 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-12-07 | 22,532 | $67.48 | 97,817 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2017-12-07 | 112,500 | $0.00 | 112,500 | $55.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-12-18 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of $67.4803. The range of prices for the sale of these shares was $67.3900 - $67.7400 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% vested on 4/1/2016.